The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study
Clinical trial NCT07078292 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07078292
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-03-31
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.